"Current Valuation is Disconnected From Future Growth Outlook" - William Blair Reiterates Collegium Pharmaceutical (COLL) at Outperform
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on Collegium Pharmaceutical (NASDAQ: COLL)The analyst comments: "We continue to believe ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
